These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
895 related articles for article (PubMed ID: 33748740)
21. A Review of SARS-CoV-2 and the Ongoing Clinical Trials. Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the Respiratory Viral Panel PCR Test Results Before and After COVID-19 Pandemic]. Alp A; Taşçı O; Ergin A; Köseoğlu Eser Ö Mikrobiyol Bul; 2022 Oct; 56(4):667-681. PubMed ID: 36458713 [TBL] [Abstract][Full Text] [Related]
23. An overview on the current available treatment for COVID-19 and the impact of antibiotic administration during the pandemic. Paula HSC; Santiago SB; Araújo LA; Pedroso CF; Marinho TA; Gonçalves IAJ; Santos TAP; Pinheiro RS; Oliveira GA; Batista KA Braz J Med Biol Res; 2021; 55():e11631. PubMed ID: 34909910 [TBL] [Abstract][Full Text] [Related]
24. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
25. A Review of Potential Therapeutic Strategies for COVID-19. Meng J; Li R; Zhang Z; Wang J; Huang Q; Nie D; Fan K; Guo W; Zhao Z; Han Z Viruses; 2022 Oct; 14(11):. PubMed ID: 36366444 [TBL] [Abstract][Full Text] [Related]
26. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Al-Shamsi HO; Alhazzani W; Alhuraiji A; Coomes EA; Chemaly RF; Almuhanna M; Wolff RA; Ibrahim NK; Chua MLK; Hotte SJ; Meyers BM; Elfiki T; Curigliano G; Eng C; Grothey A; Xie C Oncologist; 2020 Jun; 25(6):e936-e945. PubMed ID: 32243668 [TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199 [TBL] [Abstract][Full Text] [Related]
28. A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic. Rehman S J Infect Public Health; 2023 Apr; 16(4):611-617. PubMed ID: 36857834 [TBL] [Abstract][Full Text] [Related]
29. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario. Gudadappanavar AM; Benni J J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964 [TBL] [Abstract][Full Text] [Related]
30. A Reminder of Skin Cancer During the COVID-19 Pandemic. Šitum M; Filipović N; Buljan M Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068 [TBL] [Abstract][Full Text] [Related]
31. An Insight Into COVID-19: A 21st Century Disaster and Its Relation to Immunocompetence and Food Antioxidants. Siddique F; Abbas RZ; Mansoor MK; Alghamdi ES; Saeed M; Ayaz MM; Rahman M; Mahmood MS; Iqbal A; Manzoor M; Abbas A; Javaid A; Hussain I Front Vet Sci; 2020; 7():586637. PubMed ID: 33521076 [TBL] [Abstract][Full Text] [Related]
32. Potential health benefits of zinc supplementation for the management of COVID-19 pandemic. Oyagbemi AA; Ajibade TO; Aboua YG; Gbadamosi IT; Adedapo ADA; Aro AO; Adejumobi OA; Thamahane-Katengua E; Omobowale TO; Falayi OO; Oyagbemi TO; Ogunpolu BS; Hassan FO; Ogunmiluyi IO; Ola-Davies OE; Saba AB; Adedapo AA; Nkadimeng SM; McGaw LJ; Kayoka-Kabongo PN; Oguntibeju OO; Yakubu MA J Food Biochem; 2021 Feb; 45(2):e13604. PubMed ID: 33458853 [TBL] [Abstract][Full Text] [Related]
33. Microbial Metabolites: The Emerging Hotspot of Antiviral Compounds as Potential Candidates to Avert Viral Pandemic Alike COVID-19. Raihan T; Rabbee MF; Roy P; Choudhury S; Baek KH; Azad AK Front Mol Biosci; 2021; 8():732256. PubMed ID: 34557521 [TBL] [Abstract][Full Text] [Related]
34. Multilevel Engagements of Pharmacists During the COVID-19 Pandemic: The Way Forward. Mallhi TH; Liaqat A; Abid A; Khan YH; Alotaibi NH; Alzarea AI; Tanveer N; Khan TM Front Public Health; 2020; 8():561924. PubMed ID: 33364224 [TBL] [Abstract][Full Text] [Related]
35. The microbial coinfection in COVID-19. Chen X; Liao B; Cheng L; Peng X; Xu X; Li Y; Hu T; Li J; Zhou X; Ren B Appl Microbiol Biotechnol; 2020 Sep; 104(18):7777-7785. PubMed ID: 32780290 [TBL] [Abstract][Full Text] [Related]
36. Pipeline Pharmacological Therapies in Clinical Trial for COVID-19 Pandemic: a Recent Update. Kumari P; Rawat K; Saha L Curr Pharmacol Rep; 2020; 6(5):228-240. PubMed ID: 32837854 [TBL] [Abstract][Full Text] [Related]
37. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19. Kumar S; Zhi K; Mukherji A; Gerth K Viruses; 2020 Apr; 12(5):. PubMed ID: 32357553 [TBL] [Abstract][Full Text] [Related]
38. TB and COVID-19: An Exploration of the Characteristics and Resulting Complications of Co-infection. Luke E; Swafford K; Shirazi G; Venketaraman V Front Biosci (Schol Ed); 2022 Mar; 14(1):6. PubMed ID: 35320917 [TBL] [Abstract][Full Text] [Related]
39. Association between bisphosphonate use and COVID-19 related outcomes. Thompson J; Wang Y; Dreischulte T; Barreiro O; Gonzalez RJ; Hanč P; Matysiak C; Neely HR; Rottenkolber M; Haskell T; Endres S; von Andrian UH Elife; 2023 Aug; 12():. PubMed ID: 37534876 [TBL] [Abstract][Full Text] [Related]
40. Comprehensive analyses of bioinformatics applications in the fight against COVID-19 pandemic. Ma L; Li H; Lan J; Hao X; Liu H; Wang X; Huang Y Comput Biol Chem; 2021 Dec; 95():107599. PubMed ID: 34773807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]